Vasanthakumar Sekar

413 total citations
15 papers, 327 citations indexed

About

Vasanthakumar Sekar is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vasanthakumar Sekar has authored 15 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vasanthakumar Sekar's work include Nanoparticle-Based Drug Delivery (3 papers), Advanced Drug Delivery Systems (3 papers) and Liver physiology and pathology (2 papers). Vasanthakumar Sekar is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), Advanced Drug Delivery Systems (3 papers) and Liver physiology and pathology (2 papers). Vasanthakumar Sekar collaborates with scholars based in India, United States and Malaysia. Vasanthakumar Sekar's co-authors include Ranendra Narayan Saha, Girish Bende, Mandip Singh, Ketan Patel, Ravi Doddapaneni, Nusrat Chowdhury, Samir Banerjee, Anup Kumar Bhowmick, P. Sasikala and Balachandar Vellingiri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Vasanthakumar Sekar

15 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vasanthakumar Sekar India	7	141	102	83	72	58	15	327
Muhammad Waseem Khan Pakistan	10	115 0.8×	129 1.3×	77 0.9×	114 1.6×	38 0.7×	15	383
Pallavi Chand India	8	139 1.0×	149 1.5×	127 1.5×	62 0.9×	46 0.8×	10	364
Shijun Jiang China	12	170 1.2×	115 1.1×	51 0.6×	88 1.2×	51 0.9×	18	398
Farshid Hassanzadeh Iran	14	158 1.1×	175 1.7×	91 1.1×	106 1.5×	40 0.7×	37	448
Chengan Du United States	6	193 1.4×	134 1.3×	75 0.9×	39 0.5×	71 1.2×	12	375
Shaomei Yang China	11	227 1.6×	187 1.8×	107 1.3×	45 0.6×	53 0.9×	22	484
Vivek Makwana Australia	8	235 1.7×	85 0.8×	53 0.6×	104 1.4×	42 0.7×	10	436
Nikhil Rai India	11	149 1.1×	122 1.2×	117 1.4×	34 0.5×	53 0.9×	21	359
Guimin Xia China	12	231 1.6×	169 1.7×	124 1.5×	57 0.8×	66 1.1×	24	470
Kaipei Luo China	11	147 1.0×	119 1.2×	103 1.2×	33 0.5×	50 0.9×	15	354

Countries citing papers authored by Vasanthakumar Sekar

Since Specialization

Citations

This map shows the geographic impact of Vasanthakumar Sekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasanthakumar Sekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasanthakumar Sekar more than expected).

Fields of papers citing papers by Vasanthakumar Sekar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vasanthakumar Sekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasanthakumar Sekar. The network helps show where Vasanthakumar Sekar may publish in the future.

Co-authorship network of co-authors of Vasanthakumar Sekar

This figure shows the co-authorship network connecting the top 25 collaborators of Vasanthakumar Sekar. A scholar is included among the top collaborators of Vasanthakumar Sekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vasanthakumar Sekar. Vasanthakumar Sekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Sekar, Vasanthakumar & K. Srinivasan. (2025). Control and guidance for quadcopter aerial vehicle using extremum seeking-active disturbance rejection control. Sadhana. 50(4). 1 indexed citations

Sekar, Vasanthakumar, et al.. (2023). Targeting liver cancer stem cell through EpCAM therapy targeted with chemotherapy endorse enhanced progression in hepatocellular carcinoma. SHILAP Revista de lepidopterología. 13(1). 6 indexed citations

Sekar, Vasanthakumar, et al.. (2020). The Role of Self-Nanoemulsifying Drug Delivery Systems of CDODA-Me in Sensitizing Erlotinib-Resistant Non–Small Cell Lung Cancer. Journal of Pharmaceutical Sciences. 109(6). 1867–1882. 20 indexed citations

Sekar, Vasanthakumar, et al.. (2018). UNDERSTANDING THE MECHANISM OF DRUG-RESISTANT AND TUMOR RECURRENCE IN LIVER CANCER. Journal of Drug Delivery and Therapeutics. 8(5). 224–229. 2 indexed citations

Sekar, Vasanthakumar, et al.. (2017). EpCAM as a novel therapeutic target for hepatocellular carcinoma. SHILAP Revista de lepidopterología. 3(2). 71–76. 26 indexed citations

Radhakrishnan, Padhma, Vasanthakumar Sekar, Priyanka Chevour, et al.. (2017). Abstract 3681: A patient derived ex vivo platform CANScript™ predicts distinct therapeutic outcomes to multiple PD-1 checkpoint inhibitors in single tumor biopsies. Cancer Research. 77(13_Supplement). 3681–3681. 3 indexed citations

Sekar, Vasanthakumar, et al.. (2016). Molecular and Functional Diagnostic Tools in Precision Oncology for Urological Malignancies. Indian Journal of Surgical Oncology. 8(1). 24–32. 1 indexed citations

Sekar, Vasanthakumar, Biswanath Majumder, Samir Banerjee, et al.. (2016). CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer. Cellular Oncology. 40(2). 145–155. 43 indexed citations

Patel, Ketan, Ravi Doddapaneni, Vasanthakumar Sekar, Nusrat Chowdhury, & Mandip Singh. (2016). Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer. Molecular Pharmaceutics. 13(6). 2049–2058. 41 indexed citations

10.

Sekar, Vasanthakumar, Haja Nazeer Ahamed, & Ranendra Narayan Saha. (2014). Nanomedicine I: In vitro and in vivo evaluation of paclitaxel loaded poly-(ε-caprolactone), poly (dl-lactide-co-glycolide) and poly (dl-lactic acid) matrix nanoparticles in wistar rats. European Journal of Drug Metabolism and Pharmacokinetics. 40(2). 137–161. 6 indexed citations

11.

Sekar, Vasanthakumar, et al.. (2013). DETERMINATION OF PACLITAXEL BY 3D VIEW LC-DIODE ARRAY UV: ITS APPLICATION TO AN IN SITU CLOSED LOOP RE-CIRCULATING INTESTINE ABSORPTION STUDY IN RATS. Journal of Liquid Chromatography & Related Technologies. 36(19). 2698–2730. 1 indexed citations

12.

Raghavan, Chellan Vijaya, et al.. (2010). In vitro and in vivo evaluation of Moringa gum as a carrier for buccal drug delivery.. 32(2). 71–80. 1 indexed citations

13.

Saha, Ranendra Narayan, et al.. (2010). Nanoparticulate drug delivery systems for cancer chemotherapy. Molecular Membrane Biology. 27(7). 215–231. 126 indexed citations

14.

Sekar, Vasanthakumar, et al.. (2008). In vitro and in vivo evaluation of locust bean gum and chitosan combination as a carrier for buccal drug delivery.. PubMed. 63(5). 342–7. 17 indexed citations

15.

Sekar, Vasanthakumar, et al.. (2008). Immediate Release Tablets of Telmisartan Using Superdisintegrant-Formulation, Evaluation and Stability Studies. Chemical and Pharmaceutical Bulletin. 56(4). 575–577. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact